Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × ARQ 197 × Clear all

NCT01575522 2016-03-21

Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer

Phase 2 Completed

22 enrolled 10 charts

Breast Neoplasms, Triple Negative Breast Neoplasms